Kristine Ashcraft

500 total citations
11 papers, 315 citations indexed

About

Kristine Ashcraft is a scholar working on Pharmacology, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kristine Ashcraft has authored 11 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Geriatrics and Gerontology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kristine Ashcraft's work include Pharmacogenetics and Drug Metabolism (9 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical studies and practices (4 papers). Kristine Ashcraft is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical studies and practices (4 papers). Kristine Ashcraft collaborates with scholars based in United States. Kristine Ashcraft's co-authors include Ranjit K. Thirumaran, John C. Henderson, Moni B. Neradilek, Adam P. Bress, Sudhir Unni, Diana Brixner, Xiangyang Ye, Joseph Biskupiak, Richard Newman and John R. White and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Health-System Pharmacy.

In The Last Decade

Kristine Ashcraft

11 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristine Ashcraft United States	7	210	136	83	57	56	11	315
JS Schildcrout United States	2	217 1.0×	141 1.0×	24 0.3×	65 1.1×	47 0.8×	2	297
Dyson T. Wake United States	8	241 1.1×	165 1.2×	31 0.4×	61 1.1×	56 1.0×	13	358
Carolyn R. Rohrer Vitek United States	12	267 1.3×	158 1.2×	36 0.4×	109 1.9×	52 0.9×	17	398
Katarzyna Drozda United States	11	337 1.6×	110 0.8×	25 0.3×	56 1.0×	37 0.7×	16	440
Leland E. Hull United States	9	112 0.5×	86 0.6×	19 0.2×	104 1.8×	38 0.7×	22	284
Emily J. Cicali United States	9	170 0.8×	99 0.7×	14 0.2×	36 0.6×	33 0.6×	28	261
Laura Train United States	6	136 0.6×	80 0.6×	21 0.3×	43 0.8×	28 0.5×	10	289
Kristin Wiisanen United States	9	162 0.8×	88 0.6×	16 0.2×	33 0.6×	25 0.4×	20	213
C. L. Vnencak-Jones United States	5	189 0.9×	91 0.7×	16 0.2×	96 1.7×	34 0.6×	6	373
Kenneth D. Levy United States	7	138 0.7×	107 0.8×	19 0.2×	116 2.0×	71 1.3×	13	301

Countries citing papers authored by Kristine Ashcraft

Since Specialization

Citations

This map shows the geographic impact of Kristine Ashcraft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine Ashcraft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine Ashcraft more than expected).

Fields of papers citing papers by Kristine Ashcraft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristine Ashcraft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine Ashcraft. The network helps show where Kristine Ashcraft may publish in the future.

Co-authorship network of co-authors of Kristine Ashcraft

This figure shows the co-authorship network connecting the top 25 collaborators of Kristine Ashcraft. A scholar is included among the top collaborators of Kristine Ashcraft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristine Ashcraft. Kristine Ashcraft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Shriver, Sharon P., Jeannine S. McCune, Dale Miles, et al.. (2024). Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology. Journal of Clinical Oncology. 42(10). 1181–1192. 9 indexed citations

Ashcraft, Kristine, et al.. (2023). Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?. Journal of the American Pharmacists Association. 63(3). 939–945. 1 indexed citations

Dalton, Rachel, et al.. (2022). Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program. Journal of Personalized Medicine. 12(2). 161–161. 5 indexed citations

Schmidlen, Tara, et al.. (2022). Implementing comprehensive pharmacogenomics in a community hospital–associated primary care setting. Journal of the American Pharmacists Association. 63(1). 188–192. 9 indexed citations

Ashcraft, Kristine, et al.. (2022). Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population. Journal of Personalized Medicine. 12(12). 1972–1972. 4 indexed citations

Ashcraft, Kristine, et al.. (2021). Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study. Journal of Personalized Medicine. 11(11). 1192–1192. 6 indexed citations

Nazareth, Shivani, et al.. (2020). Democratizing genomics: Leveraging software to make genetics an integral part of routine care. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 187(1). 14–27. 25 indexed citations

Henderson, John C., et al.. (2017). Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial. PLoS ONE. 12(2). e0170905–e0170905. 104 indexed citations

Brixner, Diana, Adam P. Bress, Sudhir Unni, et al.. (2015). The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. Journal of Medical Economics. 19(3). 213–228. 103 indexed citations

10.

White, John R., et al.. (2015). Cytochrome P–450 gene and drug interaction analysis in patients referred for pharmacogenetic testing. American Journal of Health-System Pharmacy. 73(2). 61–67. 45 indexed citations

11.

Ashcraft, Kristine, et al.. (2008). Genelex Corporation. Pharmacogenomics. 9(4). 469–475. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact